FDA asks Map to address Levadex manufacturing issues
The FDA did not complete the review of Levadex’s new drug application, because of chemistry, manufacturing and controls issues observed during an inspection of the third-party manufacturer, the
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
The solution leverages LabConnect’s software, SampleREACH, which provides web-based sample tracking including collection, shipment, and receipt at any laboratory or location worldwide. The software enables instant accessioning and
The automated software systems will replace previous manual, paper-based CAPA and complaints processes, the Pharmaceutical Associates said. Pilgrim’s CAPA Management and Complaints Management form a closed-loop system that